Radiofrequency ablation versus laparoscopic hepatectomy for hepatocellular carcinoma: a Meta-analysis
10.3760/cma.j.cn113884-20210622-00204
- VernacularTitle:腹腔镜肝切除与射频消融治疗肝细胞癌疗效的荟萃分析
- Author:
Qingbo FENG
1
;
Jie QIU
;
Yuanlin LIU
;
Jian ZHANG
;
Jingyuan HUANG
;
Haoming WANG
;
Kunming WEN
Author Information
1. 贵州茅台医院普外科，遵义 563003
- Keywords:
Carcinoma, hepatocellular;
Radiofrequency ablation;
Laparoscopic hepatectomy;
Meta-analysis
- From:
Chinese Journal of Hepatobiliary Surgery
2022;28(3):221-227
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To compare the effectiveness and safety of laparoscopic hepatectomy (LH) versus radiofrequency ablation (RFA) in treatment of hepatocellular carcinoma (HCC).Methods:The medical literatures on LH and RFA for HCC were searched in PubMed, Web of Science, Embase, VIP, Wanfang, CNKI and other electronic databases. The retrieval date was from database construction to June 7, 2021. According to the inclusion and exclusion criteria, studies were extracted by two authors, and Revman 5.3 software was used to conduct a meta-analysis to compare differences in operation time, blood loss, length of hospital stay, total complications, overall survival and disease-free survival outcomes between the LH group and the RFA group.Results:Of 3 690 patients who were included in 32 studies, there were 1 708 patients in the LH group and 1982 patients in the RFA group. Meta-analysis showed that compared with the LH group, the RFA group had significantly shorter surgical duration ( MD=-86.41, 95% CI: -116.21--56.60), less blood loss ( MD=-213.22, 95% CI: -273.43--153.00), shorter hospital stay ( MD=-3.23, 95% CI: -4.13--2.32), and lower incidence of complications ( OR=0.33, 95% CI: 0.26-0.43). However, local recurrence rate was significantly higher ( OR=1.83, 95% CI: 1.38-2.41). (All P<0.05). The 5-year survival rate of the LH group was significantly better than the RFA group ( OR=0.68, 95% CI: 0.51-0.90, P=0.008). Conclusion:LH provided better overall survival outcomes and lower local recurrence rates than RFA in HCC patients.
